Session VI
Translational II

Programme

• 08:30 – 08:40 8 Min. 2 Min.

  • Oral presentation
  • O44

  Application of liquid biopsy in the clinical management of pancreatic cancer patients

  • Dr. Jörg Hoheisel (Heidelberg / DE)

   Pancreatic cancer
• 08:40 – 08:50 8 Min. 2 Min.

  • Oral presentation
  • O45

  Peri-anastomotic stent placement for internal drainage of pancreatic fistula following pancreato-gastrostomy

  • Dr. Matthäus Felsenstein (Berlin / DE)

   Pancreatic endoscopy and intervention
• 08:50 – 09:00 8 Min. 2 Min.

  • Oral presentation
  • O46

  Obesity-Driven early pancreatic cancer

  • Sally Kfoury (Heidelberg / DE)

   Pancreatic cancer
• 09:00 – 09:10 8 Min. 2 Min.

  • Oral presentation
  • O47

  Comprehensive analysis of the TIGIT-axis identifies the immunologic and clinical significance of Nectin-4 in pancreatic cancer

  • PD Dr. med. Adrian Seifert (Dresden / DE)

   Pancreatic cancer
• 09:10 – 09:20 8 Min. 2 Min.

  • Oral presentation
  • O48

  Liquid biopsy shows distinctive proteome of long-term recurrence free survival after resection of pancreatic cancer

  • Teresa Colbatzky (Heidelberg / DE)
  • PD Dr. Ulrike Heger (Heidelberg / DE)

   Pancreatic cancer
• 09:20 – 09:30 8 Min. 2 Min.

  • Oral presentation
  • O49

  Modelling Johanson-Blizzard-Syndrome in a dish – molecular insights into UBR1 deficiency using pluripotent stem cell-derived ancreatic organoids

  • Leon Reichardt (Ulm / DE)

   Tumour microenvironment, epigenetics and stem cells
• 09:30 – 09:40 8 Min. 2 Min.

  • Oral presentation
  • O50

  Endoscopic papillectomy for ampullary lesions of minor papilla

  • Dr. Marcus Hollenbach (Heidelberg / DE)

   Pancreatic endoscopy and intervention
• 09:40 – 09:50 8 Min. 2 Min.

  • Oral presentation
  • O51

  Differenziertes Drainagemanagement mit frühzeitiger Fistelspülung senkt Reinterventionsnotwendigkeit und Mortalität bei Pankreasresektionen

  • Dr. Alexander Gluth (Düsseldorf / DE)
  • Prof. Dr. Werner Hartwig (Düsseldorf / DE)

   Pancreatic cancer
• 09:50 – 10:00 8 Min. 2 Min.

  • Oral presentation
  • O52

  PROTOCOL trial – PROTon pump inhibitors and stent OCclusion rate Of Lumen apposing metal stents

  • Dr. Jacob Hamm (Göttingen / DE)

   Acute/chronic pancreatitis